Data Integrity Library
This library is a collection of up to date publications associated with the topic of data governance and data integrity. The collection is divided into four main groups with each of those further subdivided by country or topic. The intent is to maintain this as a living collection with frequent updates.
Regulations And Guidance
Included in this category are health authority regulations, guidance and guidelines associated with data governance and data integrity. They are divided by country specific health authority.
China
- SFDA-Drug-Data-Management-Standard (English Version)
- SFDA-draft-Data-Management-Standard_October-2016
EMA
FDA
- Data Integrity and Compliance with Drug CGMP Questions & Answers
- CFR-Code-of-Federal-Regulations-Title-21-Part-11-Elecronic-Records-Electronic-Signatures
- Preamble-to-21CFR-Part-11_March-20_1997
- Guidance-Blood-Establishment-Computer-System-Validation
- Guidance-Circumstances-that-Constitute-Delay_Deny_Limit_Refusal-of-Inspection
- Guidance-Computerized-Systems-Used-in-Clinical-Investigations_2007
- Guidance-Electronic-Source-Data-in-Clinical-Investigations_2013
- Guidance-Principles-of-Software-Validation_2002
- Level-2-Guidance_see-Question-3
MHRA
PIC/S
Health Canada
World Health Organization (WHO)
Regulator Enforcement Actions
Included in this category are health authority regulations, guidance and guidelines associated with data governance and data integrity. They are divided by country specific health authority.
FDA
- Form 483, Able Laboratories, 2005
- Ranbaxy Consent Decree Agreement
- WL-DSM-N.V.
- Warning Letter, CRS USA
- WL-National-Genetics-Institute
- Warning Letter, Sri Krishna
- Warning Letter, Sun Pharmaceutical Industries
- Warning Letter Summary and Analysis, Data Integrity Deficiencies, 2015
- Warning Letter, Bayer AG
- Concept Heidelberg, FDA warning letters, 2013, Laboratory Data Integrity
WHO
- Notice of Concern, Quest Life Sciences, 2015
- Notice of Concern issued to Cadila Healthcare Limited, January 29, 2016
OTHER
Regulator Presentations & Blogs
This section provides slide decks, blogs and other articles written and presented by health authorities on the topic of data governance and data integrity. These are divided by country and specific authors and years of presentation / publication are identified.
Below are Regulator Presentations and Blogs that were considered during the development of the Rx-360 Data Integrity Audit Manual.
FDA
- Brooke Higgins 2016
- Robert Tollefsen, 2010
- Karen Takahashi, PDA, 2014
- Karen Takahashi FDA Guidance
- Paula Katz, PDA, 2016
- Sarah Barkow, ISPE, 2016
- Data Integrity Rocking the Foundation by Douglas Stearn
- Rocking the Foundation Data Integrity Questions by Douglas Stearn, 2014
- Current Inspectional and Compliance Issues in Data Integrity by Carmelo Rosa, 2014
- ICHQ7 Principles and Data Integrity by Carmelo Rosa, 2014
- Preventing, Detecting and Responding to Data Integrity Events by Paula Katz, 2015
- Our Global Drug Supply – Containing the Challenges by Ilisa Bernstein, 2014
HPRA
- Ciara Turley, PDA, 2015
- Computerised Systems, Inspection Expectations by Paul Moody, 2013
- Computerised System Validation, Considerations for the Validation Lifecycle by Paul Moody, 2014
MARA
- Rachel Carmichael, Sept 2014
- Data Integrity Issues – Understanding and Resolution by Rachel Carmichael, 2014
- Ewan Norton, 2015
- MHRA 3-series Inspectorate Blog on Data Integrity
- MHRA_GMP_Inspection_Deficiency_Data_Trend_2016
- MHRA GMP Inspection Deficiency Data Trend 2015 (see slides 63 -66)
- MHRA GMP Inspection Deficiency Data Trends 2016 (see slides 29-32 and 81-84)
- MHRA GMP Symposium, 2014
- MHRA GMP Symposium, 2015
- MHRA-GMP-Inspection-Deficiency-data-trend-2016-PPT
- Data Integrity An EU Perspective by Gerald Heddell, 2014
- Good Documentation Practices – Documentation Requirements for Regulated Environments
TGA
OTHER ARTICLES & PRESENTATIONS
Below are Articles and Presentations that were considered during the development of the Rx-360 Data Integrity Audit Manual.
AGILENT
WATERS
LEGAL
ISPE
- ISPE Data Integrity Critical Thinking
- ISPE-Data-Integrity-Concept-Paper
- ISPE-Records-Data-Integrity-Table-of-Contents
- Paul Smith_Confused by Data Integrity Guidance
IPEC
PDA
- Points-to-consider_Application-Integrity-Policy
- Ireland Chapter Data Integrity Seminar Introduction May 2014
- PDA is Tackling the Data Integrity Topic by Richard Johnson, 2016
APIC
PharmTech
- Data-Integrity_Siegfried-Schmitt_July-2014
- Data Integrity in the Analytical Laboratory by Paul Smith, 2014
- Data-Integrity-Key-to-GMP-Compliance_Jill-Wechsler_September-2014
- Data-Integrity-Getting-Back-to-Basics_Richard-Johnson_September-2015
- FDAs-Focus-on-Laboratory-Data-Integrity-–-Part-1_D-McDowall_September-2013
INDIA
R.D. McDowall
- Where-Can-I-Draw-The-Line-By-R.D.-McDowall-2015
- How-Can-LIMS-Help-Ensure-Data-Integrity-by-R.D.-McDowall-2016
- The-Role-of-Chromatography-Data-Systems-in-Fraud-and-Falsification-by-R.D.-McDowall-2014
- Welcome-to-the-Brave-New-World-of-CSV-by-R.D.-McDowall-2016
- Paper-Paper-Everywhere-but-None-of-it-Controlled
- MHRA-GMP-Data-Integrity-Definitions-and-Guidance-for-Industry-Initial-Review-and-Critique-by-R.D.-McDowall-2015
- How-Complete-Are-Your-Data-by-R.D.-McDowall-2013
- Comparison-of-FDA-and-EU-Regulations-for-Audit-Trails-by-R.D.-McDowall-2014
- Fat-Finger-Falsification-or-Fraud-by-R.D.-McDowall-2010
- Can-You-Meet-the-Technical-Requirements-of-Annex-11-by-R.D.-McDowall-2012
- The-Ideal-Chromatogrpahy-Data-Systems-for-a-Regulated-Laboratory-Part-1-The-Complaint-Analytical-Process-by-R.D.-McDowall-2016
- The-Ideal-Chromatography-Data-Systems-for-a-Regulated-Laboratory-Part-II-System-Architecture-Requirements-by-R.D.-McDowall-2015
- The Ideal Chromatography Data System for a Regulated Laboratory, Part III: Essential Chromatographic Functions for Electronic Ways of Working
- The-Ideal-Chromatography-Data-Systems-for-a-Regulated-Laboratory-Part-IV-Ensuring-Regulatory-Compliance-by-R.D.-McDowall-2016 (1)
- Is-GMP-Annex-11-Europes-Answer-to-21-CFR-11-by-R.D.-McDowall-2011
- What-is-Data-Integrity-Training-by-R.D.-McDowall-2015
- What-Exactly-Are-Raw-Data-by-R.D.-McDowall-2016
- Whats-New-With-the-FDAs-Data-Integrity-Guidance-by-R.D.-McDowall-2016
- Understanding-the-Layers-of-a-Laboratory-Data-Integrity-Model-by-R.D.-McDowall-2016
- Can-you-Demonstrate-the-Integrity-of-Your-Data-by-R.D.-McDowall-2014
Katherine Eban
- Ranbaxys-Empty-Promises-by-Kathrine-Eban-2014
- The-Epic-Inside-Story-of-Long-Term-Criminal-Fraud-at-Ranbaxy-the-Indian-Drug-Company-that-Makes-Generic-Lipitor-for-Millions-of-Americans-by-Katherine-Eban-2013
Colgin Consulting
- What-Are-The-Records-Anyway-by-Jamie-Colgin
- The-Top-3-Actions-You-Can-Take-To-Protect-Your-Companys-ePRO-Patient-Reported-Outcomes-Data-by-Jamie-Colgin
- Why-Isnt-Paper-the-Same-as-Electronic-by-Jamie-Colgin
- Invisible-Ink-in-GLP-and-GCP-Research-by-Jamie-Colgin
- 3-Tips-for-EDC-Audit-Trails-by-Jamie-Colgin-2014
- 5-Questions-You-Should-Ask-Your-GLP-GCP-Labs-and-the-answers-you-need-to-know-by-Jamie-Colgin-2013
Unger Consulting Inc.
- Data-Integrity-White-Paper-BLOG_Unger-Consulting-Inc
- Data Governance and Data Integrity Warning Letters 2017
- CY2018 Data Integrity Warning Letters
OTHER
- FDA_ORA Spreadsheet Validation_
- EY survey by Fraud Investigation & Dispute Services, Analyzing the State of Data Integrity Compliance in the Indian Pharmaceutical Industry
- Concept Heidelberg, FDA warning letters, 2013, Laboratory Data Integrity
- IVT Network, Data Integrity – FDA and Global Regulatory Guidance, October 2014
- IVT meeting, April 2015. Ensuring Data Integrity by Joseph Zec
- NSF Journal, Issue 28, Spring 2014, Data Integrity, A Modern Day Challenge
- Dinesh Thakur, slide deck from Rx-360 Annual meeting November 2016
- Medassure: Securing the Supply Chain, Dinesh Thakur
- Legal Aspects of Data Integrity by Jennifer Zachary, 2014
- Data Integrity Throughout the Computerized System Lifecycle by Sion Wyn, 2014
- How Could 5,000 Employees Be So Deceptive? Science Explains the Wells Fargo Scandal by Justin Bariso, 2016
- Importance of Data Integrity in Corporate Lifecycle – Ethics by Paul Vogel and Barry Rothman, 2014
- Unease Grows Among U.S. Doctors Over Indian Drug Quality by Toni Clarke and Bill Berkrot, 2014
- Securing Reliable Supply From India by David Smith, 2014
- Study Warns That Science As We Know It Is Evolving Into Something Shoddy and Unreliable by Peter Dockrill, 2016
- Data Integrity Training Lessons Learned & Case Studies by Monica Cahilly, 2015
- Data Governance Planning by McGee Pharma International, 2015
- Data Integrity: Success by Design by Trevor Schoerie, 2015
- Data Quality and the Origin of ALCOA by Stan Woolen, 2010
- People Aspects: Ensuring Training Resources, and Environment Promoting Good Documentation Practices by Joseph Famulare, 2015
- Data Integrity in the Regulated Laboratory by Mark Newton, 2014
- Responding to the FDA & Basic Remediation by 5WS Consulting, 2017
- ive Questions you Need to Answer by PharmaCompass, 2015
- PDA is Tackling the Data Integrity Topic by Richard Johnson, 2016
- $20 Andromeda Strains Hyperion as Fake Data Ends Diabetes Drug Development by Dan Stanton, 2014
- Ensuring Data Integrity by John Avellent, 2011
- Detecting GMP Data Integrity Issues by Elaine Eborall, 2014
- Data Integrity in the Analytical Laboratory by Paul Smith, 2014
- Data Integrity in Clinical Trials by Tom Haag, 2014
- Detecting Data Integrity Issues by Mark Newton, 2017
- Data Integrity Audits: Pitfalls, Expectations & Experiences by Mark Dickson
- CSV Considerations Around Data Integrity by Propharmagroup
- 80% of Data in Chinese Clinical Trials Have Been Fabricated by Fiona MacDonald, 2016
- Measuring Effectiveness of Data Integrity by Rebecca Brewer, 2015
- Forensic Auditing for Data Integrity by Rebecca Brewer, 2015
- Considerations for Corporate Data Integrity Program by John Avellanet, 2014
- Understanding Audit Trail Requirements in Electronic GxP Systems by Michael Zwetkow, 2015
- The Audit Trail Advantage by Carol Brandt, 2014
- Are Audit Trails Really Needed? by Richard White, 2012
- Pharmaceutical Firms Accused of Falsifying Data in Major Alzheimer’s Study by Sebastien Bozon, 2014
- Rx-360 Data Integrity Checklist _China Working Group Audit Checklist
- The Role of the Technology Provider in the Pharma Industry